Masimo

Irvine

3,639 Total Employees

Year Founded: 1989

View Website

Masimo Company Growth, Stability & Outlook

Updated on September 09, 2026

This page summarizes recurring themes identified from responses generated by popular LLMs to common candidate questions about Masimo and has not been reviewed or approved by Masimo.

What's the stability & growth outlook for Masimo?

Strengths in core revenue momentum, entrenched hospital positioning, and marquee OEM partnerships are accompanied by competitive bundling pressures, consumer‑market setbacks, and ongoing strategic/litigation noise. Together, these dynamics suggest a stable and growing clinical franchise with solid near‑term visibility, while expansion beyond the core remains more uncertain and execution‑sensitive.

Key Insight for Candidates

Steady core-growth amid structural change: Masimo’s healthcare revenue is reaccelerating, yet portfolio divestiture and a pending Danaher acquisition obscure comparability and curb standalone guidance. This means day‑to‑day momentum but shifting priorities, integration efforts, and evolving KPIs as the company refocuses on clinical monitoring and transitions into a larger parent.

Evidence in Action

Core-Only Growth Lens — Continuing operations (healthcare) metrics—Q1 2026 revenue $403.6M (+8.5% YoY)—serve as the principal growth yardstick amid the Sound United divestiture. This keeps targets clear and comparable for teams, aligning priorities and reducing noise from portfolio shifts.
Backlog-Led Revenue Visibility — Unrecognized Contract Revenue of ~$1.95B, with ~$544.5M expected within 12 months, is routinely referenced for planning and stability. This backlog orientation gives teams forecasting confidence to resource projects, plan sensor production, and sustain hiring without overreacting to quarterly fluctuations.

Positive Themes About Masimo

Strong Revenue Growth: Recent filings indicate year‑over‑year growth resumed through late 2025 into Q1 2026, with management guiding to high‑single‑digit expansion in the core healthcare business. Contracted backlog disclosed as sizable remaining performance obligations adds visibility to near‑term revenue.
Strong Market Position & Advantage: Industry analyses and partner integrations depict Masimo as a leader in hospital‑grade pulse oximetry, with entrenched use in top U.S. hospitals and broad OEM adoption. Comparative performance in motion/low‑perfusion conditions and a broad monitoring portfolio reinforce differentiation.
Strategic Partnerships: Major OEM collaborations—such as GE HealthCare integrating Masimo SET into its Portrait Mobile platform—extend reach and validate a best‑of‑breed role in acute care. Continued embedment across leading monitoring vendors supports durable channel access.

Considerations About Masimo

Failed Market Expansion: The push into consumer wearables and audio was uneven, culminating in divestiture of Sound United and a refocus on clinical markets. Legal and competitive dynamics in consumer devices—including Apple’s redesign surviving a key ITC non‑infringement determination—limit momentum outside core healthcare.
Weak Market Position & Pricing Challenges: Large incumbents and platform vendors (e.g., Medtronic/Nellcor, Philips, GE HealthCare) compete aggressively and bundle offerings, pressuring pricing and creating share variability by region and setting. Heightened scrutiny on equity and accuracy raises the bar for performance, intensifying contestation.
Strategic Drift: Portfolio shifts, discontinued operations, and ongoing litigation cycles have complicated comparability and created narrative noise around the broader strategy. Channel mix changes and tariff headwinds have added execution complexity even as core revenue trends improved.

NEW

What does AI tell candidates about your employer brand?

Get your free AI reputation report today.

See AI Report

These insights are generated using AI and may not reflect internal data or verified company information. They are intended solely for general informational purposes and should not be considered a definitive assessment of the company’s reputation. If you are a representative of this company, and would like this page to be removed, you may contact us via this form.